SCHEMBL3721028

SCHEMBL3721028

CC(Nc1nc(CN)cc(-c2ccc3c(c2)OCO3)n1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 9/20 0.48
ADORA3 P0DMS8 6/20 0.47
ADORA2A P29274 4/20 0.47
PLK1 P53350 1/20 0.46
PLK3 Q9H4B4 1/20 0.46
PLK2 Q9NYY3 1/20 0.46
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
GAA P10253 2/20 0.45
HPGD P15428 2/20 0.45
POLB P06746 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
MAPK14 Q16539 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3721096 0.78 IDH1 (0.46) MAPK14
SCHEMBL3723229 0.76 ADORA1 (0.48) ADORA1ADORA3ADORA2AKDM4EALDH1A1
SCHEMBL3721197 0.75 ADORA1 (0.51) ADORA1ADORA3ADORA2AKDM4EHPGD
SCHEMBL3719658 0.73 DYRK1A (0.49) ADORA1ADORA3ADORA2AKDM4EALDH1A1
SCHEMBL3717907 0.73 CLK4 (0.52) ADORA1ADORA3ADORA2AKDM4EALDH1A1
SCHEMBL3725579 0.73 DYRK1A (0.65) ADORA1ADORA3ADORA2AKDM4EALDH1A1
SCHEMBL3723906 0.73 PTGS2 (0.51) ADORA1ADORA3KDM4EALDH1A1GAA
SCHEMBL3724659 0.73 DYRK1A (0.51) ADORA1ADORA3ADORA2AMEN1KMT2A
SCHEMBL3722007 0.72 CLK4 (0.71) KDM4EALDH1A1GAAHPGDPOLB
SCHEMBL3720589 0.69 CLK4 (0.48) ADORA1ADORA3ADORA2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010141805-A1 HETEROCYCLIC AMIDES AS MODULATORS OF TRPA1 JANSSEN PHARMACEUTICA NV (BE) 2010-12-09 WO disclosed